NEW YORK (GenomeWeb) – Oxford Genetics said today that it has signed a worldwide distribution agreement with CLS Cell Lines Service to combine CLS's cell lines with Oxford's current menu of bio-therapeutic research products and services.

The agreement gives Oxford's customers access to over 400 mammalian cell lines which can be used in the firm's custom cell line engineering and development services.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.